AVTX
Avalo Therapeutics Inc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website avalotx.com
- Employees(FY) 20
- ISIN US05338F3064
Performance
-16.54%
1W
-39.84%
1M
+115.02%
3M
-56.57%
6M
+5.38%
YTD
-98.57%
1Y
Profile
Avalo Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development of therapies for the treatment of immune dysregulation. The company's drug candidates include AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as Crohn's disease; Phase III clinical trial for the treatment of COVID-19 acute respiratory distress syndrome; and AVTX-008, a fully human B and T Lymphocyte Attenuator (BTLA) agonist fusion protein. It also develops AVTX-803, a L-fucose monosaccharide therapy for treatment of Leukocyte Adhesion Deficiency Type II. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is headquartered in Rockville, Maryland.
Technical Analysis of AVTX 2024-05-10
Overview:
In analyzing the technical indicators for AVTX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions to guide investme...
Recent News & Updates
- 2024-05-13 03:52
- 2024-05-12 19:30
- 2024-04-01 23:30
- 2024-04-01 19:00
- 2024-03-29 04:01
- 2024-03-27 20:04
Why Is Avalo Therapeutics (AVTX) Stock Up 326% Today?(Investorplace)
- 2024-03-27 04:01
- 2024-03-26 22:00
- 2024-02-25 22:28
- 2023-12-26 18:00
Avalo Therapeutics Announces 1-for-240 Reverse Stock Split(Globenewswire)
- 2023-12-06 18:00
- 2023-11-08 18:00
- 2023-10-30 19:00
Avalo Completes Divestiture of AVTX-800 Series(Globenewswire)
- 2023-09-26 20:00
- 2023-09-25 19:00
- 2023-09-11 19:00
Avalo Enters into Agreement to Divest AVTX-800 Series(Yahoo Finance)
- 2023-09-05 19:00
- 2023-08-02 19:00
- 2023-07-06 04:01
Avalo to Participate in SVB Securities Therapeutics Forum(Yahoo Finance)
- 2023-06-25 19:00
- 2023-05-31 19:00
Avalo to Present at the Jefferies Healthcare Conference(Yahoo Finance)
- 2023-05-21 19:00
- 2023-05-14 19:00
Avalo to Present at ATS 2023 Respiratory Innovation Summit(Yahoo Finance)
- 2023-05-09 19:00
- 2023-05-04 04:01
- 2023-03-28 19:30
- 2023-03-06 18:00
- 2023-02-02 08:54
- 2023-02-02 03:01
- 2023-01-16 18:00
Page 1 of 3
previousnext